Stockreport

Director Buys $500,000 Worth of Palvella Therapeutics Shares After Phase 3 Win [Yahoo! Finance]

Palvella Therapeutics, Inc.  (PVLA) 
PDF company's underwritten public offering on Feb. 27, 2026, purchasing 4,000 shares at the offering price of $125.00 per share for a total of approximately $500,000, accord [Read more]